GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » ROE % Adjusted to Book Value

4basebio (XTER:88Q) ROE % Adjusted to Book Value : -6.52% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio ROE % Adjusted to Book Value?

4basebio's ROE % for the quarter that ended in Jun. 2023 was -136.26%. 4basebio's PB Ratio for the quarter that ended in Jun. 2023 was 20.90. 4basebio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -6.52%.


4basebio ROE % Adjusted to Book Value Historical Data

The historical data trend for 4basebio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio ROE % Adjusted to Book Value Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
ROE % Adjusted to Book Value
- - -4.00 -4.52

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial - -4.11 -6.95 -5.44 -6.52

Competitive Comparison of 4basebio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, 4basebio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4basebio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where 4basebio's ROE % Adjusted to Book Value falls into.



4basebio ROE % Adjusted to Book Value Calculation

4basebio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-53.96% / 11.95
=-4.52%

4basebio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-136.26% / 20.90
=-6.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of 4basebio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (XTER:88Q) Business Description

Industry
Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines